Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Forrester Research
FORR
$223M
| $1.2M | ﹤0.01% |
33,431
-7,544
| -18% | -$267K |
|
2177
Monolithic Power Systems
MPWR
$64.1B
| $1.2M | ﹤0.01% |
23,745
-26,354
| -53% | -$1.39M |
|
2178
iShares Core S&P 500 ETF
IVV
$894B
| $1.2M | ﹤0.01% |
5,800
-31,847
| -85% | -$6.74M |
|
|
EPZM
2179
DELISTED
Epizyme, Inc
EPZM
| $1.2M | ﹤0.01% |
50,000
-20,180
| -29% | -$388K |
|
|
HSP
2180
CALL
DELISTED
HOSPIRA INC
HSP
| $1.2M | ﹤0.01% |
13,500
-1,000
| -7% | -$88.1K |
|
2181
Q2 Holdings
QTWO
$4.05B
| $1.2M | ﹤0.01% |
42,321
-19,514
| -32% | -$456K |
|
2182
RingCentral
RNG
$5.52B
| $1.2M | ﹤0.01% |
64,637
-9,447
| -13% | -$164K |
|
2183
Mercer International
MERC
$27.7M
| $1.19M | ﹤0.01% |
87,092
-198,331
| -69% | -$2.84M |
|
2184
Cummins
CMI
$79.6B
| $1.19M | ﹤0.01% |
9,065
-87,172
| -91% | -$12M |
|
2185
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.2B
| $1.19M | ﹤0.01% |
71,645
+14,015
| +24% | +$237K |
|
2186
iShares US Technology ETF
IYW
$24.9B
| $1.18M | ﹤0.01% |
45,224
+8,880
| +24% | +$240K |
|
2187
Omnicell
OMCL
$1.53B
| $1.18M | ﹤0.01% |
31,284
-283,532
| -90% | -$10.3M |
|
|
CVGW
2188
DELISTED
Calavo Growers
CVGW
| $1.18M | ﹤0.01% |
+22,700
| New | +$1.18M |
|
|
KITE
2189
DELISTED
Kite Pharma, Inc.
KITE
| $1.18M | ﹤0.01% |
+19,318
| New | +$1.1M |
|
|
FUR
2190
DELISTED
WINTHROP REALTY TRUST SHS BENE INT (NEW)
FUR
| $1.18M | ﹤0.01% |
77,663
-23,024
| -23% | -$371K |
|
|
TAHO
2191
DELISTED
Tahoe Resources Inc
TAHO
| $1.18M | ﹤0.01% |
96,984
-18,317
| -16% | -$244K |
|
|
UAM
2192
DELISTED
Universal American Corp
UAM
| $1.17M | ﹤0.01% |
115,466
-388,213
| -77% | -$4.05M |
|
2193
Gibraltar Industries
ROCK
$1.38B
| $1.17M | ﹤0.01% |
57,340
+26,326
| +85% | +$478K |
|
|
RT
2194
DELISTED
Ruby Tuesday Georgia
RT
| $1.17M | ﹤0.01% |
186,191
+142,310
| +324% | +$956K |
|
2195
Grand Canyon Education
LOPE
$3.88B
| $1.16M | ﹤0.01% |
27,458
-108,370
| -80% | -$4.69M |
|
2196
Allient
ALNT
$1.58B
| $1.16M | ﹤0.01% |
77,580
+43,111
| +125% | +$866K |
|
2197
Mizuho Financial
MFG
$127B
| $1.16M | ﹤0.01% |
267,452
+101,099
| +61% | +$406K |
|
2198
Seagate
STX
$192B
| $1.16M | ﹤0.01% |
+24,450
| New | +$1.35M |
|
2199
NN Inc
NNBR
$292M
| $1.16M | ﹤0.01% |
+45,440
| New | +$1.2M |
|
2200
Ormat Technologies
ORA
$6.36B
| $1.16M | ﹤0.01% |
30,707
+4,763
| +18% | +$179K |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.